Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Haughney

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
COPD|January 19, 2023
Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK)Enrico de Nigris, John Haughney, Amanda J Lee, et al.
Therapeutic Advances in Respiratory Disease|February 14, 2022
The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)John Haughney, Amanda J Lee, Mintu Nath, et al.
Chest|July 15, 2006
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyRomain Kessler, Elisabeth Ståhl, Claus Vogelmeier, et al.
Respiratory Medicine|February 8, 2018
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levelsJohn Haughney, Alyn Morice, Kevin G Blyth, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|August 10, 2012
Prevalence of common chronic respiratory diseases in drug misusers: a cohort studyFrances Palmer, Mariesha Jaffray, Mandy A Moffat, et al.
Therapeutic Advances in Respiratory Disease|May 19, 2011
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?Michel Aubier, John Haughney, Olof Selroos, et al.
Respiratory Medicine|November 29, 2011
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label studyOnno C P van Schayck, John Haughney, Michel Aubier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2020
SABA Reliance Questionnaire (SRQ): Identifying Patient Beliefs Underpinning Reliever Overreliance in AsthmaAmy H Y Chan, Caroline B Katzer, Rob Horne, et al.
International Archives of Allergy and Immunology|November 8, 2011
Inhaled corticosteroid/long-acting β₂-agonist combination therapy for asthma: attitudes of specialists in EuropeJean Bousquet, Chris Winchester, Alberto Papi, et al.
Respiratory Medicine|July 13, 2019
Scottish consensus statement on the role of FeNO in adult asthmaChris RuiWen Kuo, Mark Spears, John Haughney, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
COPD|January 19, 2023
Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK)Enrico de Nigris, John Haughney, Amanda J Lee, et al.
Therapeutic Advances in Respiratory Disease|February 14, 2022
The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)John Haughney, Amanda J Lee, Mintu Nath, et al.
Chest|July 15, 2006
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyRomain Kessler, Elisabeth Ståhl, Claus Vogelmeier, et al.
Respiratory Medicine|February 8, 2018
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levelsJohn Haughney, Alyn Morice, Kevin G Blyth, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|August 10, 2012
Prevalence of common chronic respiratory diseases in drug misusers: a cohort studyFrances Palmer, Mariesha Jaffray, Mandy A Moffat, et al.
Therapeutic Advances in Respiratory Disease|May 19, 2011
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?Michel Aubier, John Haughney, Olof Selroos, et al.
Respiratory Medicine|November 29, 2011
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label studyOnno C P van Schayck, John Haughney, Michel Aubier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2020
SABA Reliance Questionnaire (SRQ): Identifying Patient Beliefs Underpinning Reliever Overreliance in AsthmaAmy H Y Chan, Caroline B Katzer, Rob Horne, et al.
International Archives of Allergy and Immunology|November 8, 2011
Inhaled corticosteroid/long-acting β₂-agonist combination therapy for asthma: attitudes of specialists in EuropeJean Bousquet, Chris Winchester, Alberto Papi, et al.
Respiratory Medicine|July 13, 2019
Scottish consensus statement on the role of FeNO in adult asthmaChris RuiWen Kuo, Mark Spears, John Haughney, et al.
Pageof 9